Immunosuppressive treatment results in patients with primary IgA nephropathy in Turkiye; the data from TSN-GOLD working group.

Aysegul Oruc Abdullah Sumnu Aydın Turkmen Taner Basturk Egemen Cebeci Kenan Turgutalp Hakkı CetinkayaMüge Uzerk KibarNurhan Seyahi Erhan Tatar Metin Ergul Ülver Derici Mehmet Deniz Ayli Musa PinarBetül BakarRumeyza Turan Kazancioglu Abdülmecit Yıldız Ahmet Burak Dirim Zulfikar Yilmaz Kultigin Turkmen Onur Tunca Mehmet Koc Sim Kutlay Hasan Micozkadıoglu Alper AzakBurcu BoztepeSedat Üstündağ Seda Safak Abdulkadir Unsal Serhat Karadag Gulizar Sahin Ezgi Coşkun Yenigün Necmi Eren Mustafa Güllülü Meltem Gursu Serdar Pop

Published in: Renal failure (2024)

CS can significantly improve remission in high-risk Turkish IgAN patients, despite the reliance on non-quantitative endpoints for favorable renal outcomes. Key predictors of remission include baseline proteinuria and specific histological markers. It is crucial to carefully weigh the risks and benefits of immunosuppressive therapy for these patients.

Keyphrases